Cargando…
Guidelines should not pool evidence from uncomplicated and severe COVID-19
Autores principales: | White, Nicholas J, Strub-Wourgaft, Nathalie, Faiz, Abul, Guerin, Philippe J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984863/ https://www.ncbi.nlm.nih.gov/pubmed/33765411 http://dx.doi.org/10.1016/S0140-6736(21)00469-4 |
Ejemplares similares
-
WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021) -
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
por: Guerin, Philippe J, et al.
Publicado: (2020) -
Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
por: Guérin, Philippe J., et al.
Publicado: (2022) -
An Uncomplicated Delivery in a Patient with Covid-19 in the United States
por: Iqbal, Sara N., et al.
Publicado: (2020) -
We should not settle for low-level evidence but should always use the best available evidence
por: Narayan, Kailash, et al.
Publicado: (2014)